Dominic S. Raj

<i>APOL1</i> Risk Variants, Race, and Progression of Chronic Kidney Disease

Afshin Parsa, W.H. Linda Kao, Dawei Xie et al. · New England Journal of Medicine · 2013 · 784 citations · Full text

Life Sciences, Genetics, Nephrology +14

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

Paul M. Ridker, Matt Devalaraja, Florian M.M. Baeres et al. · The Lancet · 2021 · 667 citations

Medicine, Immunology, Pharmacology +14

Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC

Jayanta Gupta, Nandita Mitra, Peter A. Kanetsky et al. · Clinical Journal of the American Society of Nephrology · 2012 · 596 citations · Full text

Medicine, Immunology, Nephrology +16

Fibroblast Growth Factor-23 and Cardiovascular Events in CKD

Julia J. Scialla, Huiliang Xie, Mahboob Rahman et al. · Journal of the American Society of Nephrology · 2013 · 440 citations · Full text

Medicine, Cardiology, Nephrology +17

Inflammation and Progression of CKD: The CRIC Study

Richard Amdur, Harold I. Feldman, Jayanta Gupta et al. · Clinical Journal of the American Society of Nephrology · 2016 · 438 citations · Full text

Medicine, Nephrology, Clinical Epidemiology +16